Correlation Engine 2.0
Clear Search sequence regions


Farnesoid X receptor (FXR) belongs to the nuclear receptor superfamily. It is highly related to the formation of metabolic syndrome and the glucose homeostasis, and therefore represents an important drug target against metabolic diseases and diabetes. In recent years, great progress has been made in the agonists, antagonists, and crystal structures of FXR. The diverse FXR ligands and their structure-activity relationship are reviewed in this article. The advances in the crystal structures of FXR in complex with different ligands are also introduced.

Citation

Wei-Hu Li, Jing Fu, Ming-Yue Zheng, Gui-Xia Liu, Yun Tang. Progress in the ligands and their complex structures of farnesoid X receptor]. Yao xue xue bao = Acta pharmaceutica Sinica. 2012 Jun;47(6):704-15

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22919716

View Full Text